RightFit Trial Directory

Lupus clinical trials in Chicago, IL

14 recruiting lupus studies with a site in Chicago, IL.

All trials in Chicago, IL · All Lupus trials

RecruitingPhase 3NCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sponsor: UCB Biopharma SRL

Chicago, IL · Willowbrook, IL · +61 more sites

RecruitingPhase 1 / Phase 2NCT06121297

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Sponsor: Cabaletta Bio

Chicago, IL · +19 more sites

RecruitingPhase 1NCT03816345

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI)

Chicago, IL · +49 more sites

RecruitingPhase 3NCT07691970

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Sponsor: AstraZeneca

Chicago, IL · +14 more sites

RecruitingPhase 3NCT05835310

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Sponsor: AstraZeneca

Chicago, IL · +20 more sites

RecruitingPhase 2NCT07328581

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Sponsor: iCell Gene Therapeutics

Chicago, IL · +3 more sites

RecruitingPhase 2NCT05201469

VIBRANT: VIB4920 for Active Lupus Nephritis

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Chicago, IL · +16 more sites

RecruitingPhase 2NCT05538208

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

Sponsor: Children's Hospital Medical Center, Cincinnati

Chicago, IL · +17 more sites

RecruitingPhase 1 / Phase 2NCT06897930

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Sponsor: AstraZeneca

Chicago, IL · +15 more sites

RecruitingPhase 1NCT07085104

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Sponsor: Allogene Therapeutics

Chicago, IL · +15 more sites

RecruitingPhase 1NCT06925542

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Sponsor: CRISPR Therapeutics

Chicago, IL · +8 more sites

RecruitingPhase 1 / Phase 2NCT06557265

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Sponsor: Nkarta, Inc.

Chicago, IL · +16 more sites

RecruitingPhase not listedNCT00198068

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Sponsor: Hospital for Special Surgery, New York

Chicago, IL · +6 more sites

RecruitingPhase not listedNCT05934149

Lupus Landmark Study: A Prospective Registry and Biorepository

Sponsor: Lupus Research Alliance

Chicago, IL · +18 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.